Tech Company Financing Transactions
Ultima Genomics Funding Round
On 6/1/2022, Ultima Genomics raised $600 million in funding from aMoon Partners, Andreessen Horowitz and D1 Capital Partners.
Transaction Overview
Company Name
Announced On
6/1/2022
Transaction Type
Venture Equity
Amount
$600,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
7979 Gateway Blvd. 101
Newark, CA 94560
USA
Newark, CA 94560
USA
Phone
Undisclosed
Website
Email Address
Overview
At Ultima Genomics, our mission is to continuously drive the scale of genomic information to enable unprecedented advances in biology and improvements in human health.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Gilad Almogy
Chief Financial Officer
David Peoples
Chief Scientific Officer
Doron Lipson
Chief Technical Officer
Mark Pratt
General Manager
Sandy McBean
Vice President
Omer Barad
Vice President
Shani Maman
Vice President
Dan Mazur
Vice President
Florian Oberstrass
VP - Bus. Development
Josh Lauer
VP - Engineering
Nate Beckett
VP - Engineering
Songnian Rong
VP - Finance
Toni Lin
VP - Operations
Michael Shaughnessy
Browse more venture capital transactions:
Prev: 6/1/2022: Sugar Cosmetics venture capital transaction
Next: 6/1/2022: Innerwell venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs